One of the biggest triggers for the stock price increase has to do with oppenheimer analyst hartaj singh assigning sunesis pharmaceuticals a “buy” rating and a $12 price target. According to the issued ratings of 7 analysts in the last year, the consensus rating for senseonics stock is hold based on the current 2 sell ratings, 2 hold ratings and 3 buy ratings for sens.
The new note on the price target was released on march 11, 2020, representing the official price target for sunesis pharmaceuticals inc.
Snss stock price target. Learn more on snss's analyst rating history do wall street analysts like sunesis pharmaceuticals more than its competitors? The average true range (atr) for sunesis pharmaceuticals inc. Those analysts set a price target for snss stock of $12, which implies greater than 200% upside in the stock from current valuations.
Is set at 0.03, with the price to sales ratio for snss stock in the period of the last 12 months amounting to 20.96. Singh covers the healthcare sector, focusing on stocks such as vertex. Previously, the target price had yet another drop from $3 to $1, while wells fargo kept a equal weight rating on snss stock.
Looking to buy sunesis pharmaceuticals stock? Sunesis pharmaceuticals stock forecast, snss stock price prediction. Is set at 0.41, with the price to sales ratio for snss stock in the period of the last 12 months amounting to 36.30.
Has the highest price target set, predicting snss will reach $12.00 in the next twelve months. Yet despite these upgrades, analysts cut their price target 16% to us$2.67, implicitly signalling that the ongoing losses are likely to weigh negatively on. An analyst rating of 5, which is better than 5% of stocks based on data compiled by investorsobserver.
The new note on the price target was released on march 11, 2020, representing the official price target for sunesis pharmaceuticals inc. In depth view into sunesis pharmaceuticals price target including historical data from 2005, charts, stats and industry comps. Price target in 14 days:
Oppenheimer analyst hartaj singh upgraded sunesis pharmaceuticals inc. Get the stock price and latest news for snss and start trading today with zero commissions. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current wall street consensus on snss stock is a recommendation set at 2.00.
Is set at 0.04, with the price to sales ratio for snss stock in the period of the last 12 months amounting to 25.06. Oppenheimer analyst hartaj singh upgraded snss from “perform” to “outperform.” and singh also assigned snss a price target of $12. That average ranking earns sunesis pharmaceuticals, inc.
The average true range (atr) for sunesis pharmaceuticals inc. View research reports from argus and trade ideas from trading central to understand future stock performances and find high performing trade ideas. Has the lowest price target set, forecasting a price of $12.00 for sunesis pharmaceuticals in the next year.
1 wall street analysts have issued 1 year price objectives for sunesis pharmaceuticals'. The average true range (atr) for sunesis pharmaceuticals inc. According to the issued ratings of 9 analysts in the last year, the consensus rating for ansys stock is hold based on the current 1 sell rating, 5 hold ratings and 3 buy ratings for anss.
Snss) from perform to outperform with a price target of $12.00. Sunesis pharmaceuticals shares are trading higher after oppenheimer upgraded the stock from perform to outperform and announced a price target of $12 per share. What price target have analysts set for snss?
